FDA

(Newser) - A cancer drug that's the first to harness the body's immune system to destroy tumors got a thumbs-up from  the FDA's advisory panel, the New York Times reports. If approved, Provenge, a prostate cancer treatment, would be the first of the "cancer vaccines"—experimental therapies that commandeer a...